Hospital
SHC Medical Center - Yakima
SHC Medical Center - Yakima was paid $6.93M by Medicaid between Jan 2018 and Jan 2020, across 230 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.
33Billing provider infoSHC MEDICAL CENTER - YAKIMA
YAKIMA, WA 98902
YAKIMA, WA 98902
33aNPI1114443660assigned 08/16/2017
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.93M
24GClaims304,788
24DCodes billed230
24AFirst – last monthJan 2018 – Jan 2020
Compared with peers
Next to other General Acute Care Hospital providers in Washington
Rank by total paid#37 of 49
Median peer was paid$20.06M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MATHIESEN, MATHEW controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 150,190 | $3.38M | |
| 2019 | 151,192 | $3.47M | |
| 2020 | 3,406 | $86K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 20,230 | 17,234 | $1.77M |
| 96361 | Intravenous infusion, hydration; each additional hour | 20% | 5,356 | 4,274 | $1.41M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 10% | 12,015 | 10,194 | $708K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.3% | 4,287 | 3,803 | $368K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.0% | 1,742 | 1,587 | $279K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.1% | 1,974 | 1,718 | $214K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.0% | 4,599 | 3,919 | $210K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.6% | 7,106 | 2,586 | $182K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.4% | 1,313 | 1,172 | $164K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.1% | 2,160 | 1,794 | $147K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.0% | 923 | 833 | $140K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.6% | 1,048 | 967 | $108K |
218 more codes
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.4% | 651 | $99K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.3% | 4,138 | $89K |
| 10060 | 1.2% | 449 | $81K | |
| 80053 | Comprehensive metabolic panel | 1.1% | 13,225 | $75K |
| 12001 | <1% | 321 | $60K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,464 | $54K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 338 | $51K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 481 | $39K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 375 | $33K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 176 | $30K |
| 97161 | <1% | 825 | $30K | |
| 43235 | <1% | 86 | $28K | |
| 29125 | <1% | 133 | $26K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,011 | $26K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 84 | $24K |
| 84484 | <1% | 4,680 | $22K | |
| 97162 | <1% | 687 | $22K | |
| G0378 | Hospital observation service, per hour | <1% | 2,001 | $21K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 494 | $18K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,289 | $18K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,229 | $17K |
| 76830 | Ultrasound, transvaginal | <1% | 356 | $17K |
| 80050 | General health panel | <1% | 2,226 | $16K |
| 83880 | <1% | 2,971 | $15K | |
| 83605 | <1% | 1,976 | $15K | |
| 97750 | <1% | 814 | $15K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,004 | $13K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,443 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,554 | $11K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,477 | $9K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 85 | $9K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 87 | $9K |
| 80061 | Lipid panel | <1% | 2,121 | $9K |
| 12011 | <1% | 41 | $9K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 552 | $8K |
| 87040 | <1% | 934 | $8K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,142 | $8K |
| 97116 | <1% | 580 | $8K | |
| 80306 | <1% | 3,532 | $7K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 711 | $7K |
| 93458 | <1% | 17 | $6K | |
| 93971 | <1% | 81 | $6K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,045 | $6K |
| 72100 | <1% | 604 | $6K | |
| 76801 | <1% | 97 | $6K | |
| 10061 | <1% | 33 | $6K | |
| 85379 | <1% | 975 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,028 | $5K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 15 | $5K |
| 73030 | <1% | 678 | $4K | |
| 90714 | <1% | 230 | $3K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 18 | $3K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,229 | $3K |
| 73562 | <1% | 753 | $3K | |
| 84439 | <1% | 513 | $3K | |
| 76642 | <1% | 44 | $3K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 25 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,388 | $3K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 26 | $3K |
| 76937 | <1% | 86 | $3K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 119 | $3K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 65 | $3K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 64 | $3K |
| 73630 | <1% | 624 | $2K | |
| 73610 | <1% | 799 | $2K | |
| 12002 | <1% | 12 | $2K | |
| 73130 | <1% | 636 | $2K | |
| C1769 | Guide wire | <1% | 300 | $2K |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | <1% | 17 | $2K |
| 93017 | <1% | 13 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,293 | $2K |
| 73110 | <1% | 420 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 581 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 29 | $2K |
| 86780 | <1% | 149 | $2K | |
| 87070 | <1% | 1,272 | $2K | |
| 84702 | <1% | 538 | $2K | |
| 70486 | <1% | 59 | $1K | |
| 86140 | <1% | 920 | $1K | |
| 74018 | <1% | 425 | $1K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 106 | $1K |
| 36000 | <1% | 63 | $1K | |
| 85652 | <1% | 695 | $1K | |
| 84145 | <1% | 92 | $1K | |
| 87081 | <1% | 3,459 | $1K | |
| 73502 | <1% | 183 | $1K | |
| 83735 | <1% | 6,493 | $1K | |
| 83690 | <1% | 6,723 | $1K | |
| 81001 | <1% | 6,892 | $983.45 | |
| 87186 | <1% | 1,952 | $791.49 | |
| 73140 | <1% | 314 | $790.47 | |
| 72131 | <1% | 13 | $749.49 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 52 | $741.11 |
| 72040 | <1% | 76 | $729.01 | |
| 82550 | <1% | 334 | $683.05 | |
| 86900 | <1% | 505 | $654.13 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | <1% | 126 | $619.12 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 214 | $606.13 |
| 85610 | <1% | 3,912 | $587.34 | |
| 87077 | <1% | 844 | $528.94 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,823 | $469.10 |
| 81025 | <1% | 3,779 | $469.00 | |
| 87340 | <1% | 132 | $450.31 | |
| 87205 | <1% | 1,213 | $449.10 | |
| 86803 | <1% | 110 | $424.37 | |
| 86038 | <1% | 77 | $405.75 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 13 | $403.82 |
| 77080 | <1% | 13 | $403.60 | |
| 85027 | <1% | 184 | $373.71 | |
| 83550 | <1% | 68 | $360.25 | |
| 87147 | <1% | 1,003 | $336.09 | |
| 84703 | <1% | 1,296 | $322.70 | |
| 82150 | <1% | 674 | $314.76 | |
| 86901 | <1% | 604 | $312.83 | |
| 86850 | <1% | 219 | $286.81 | |
| 87088 | <1% | 564 | $256.68 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,781 | $242.61 |
| 73590 | <1% | 26 | $227.53 | |
| 72070 | <1% | 13 | $227.35 | |
| 82607 | <1% | 29 | $209.81 | |
| 86431 | <1% | 54 | $205.99 | |
| 85730 | <1% | 2,569 | $201.05 | |
| 73090 | <1% | 39 | $190.96 | |
| 83540 | <1% | 68 | $180.04 | |
| 80074 | <1% | 28 | $175.04 | |
| 84550 | <1% | 72 | $149.82 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 159 | $146.14 |
| 97035 | <1% | 53 | $143.10 | |
| 73080 | <1% | 87 | $125.68 | |
| 88313 | <1% | 29 | $124.68 | |
| 71101 | <1% | 65 | $114.44 | |
| 82140 | <1% | 211 | $112.25 | |
| 87210 | <1% | 494 | $104.49 | |
| 85007 | <1% | 54 | $102.90 | |
| 81003 | <1% | 1,682 | $93.55 | |
| 86704 | <1% | 16 | $89.96 | |
| 73560 | <1% | 12 | $89.94 | |
| 87807 | <1% | 602 | $83.88 | |
| 86701 | <1% | 14 | $64.01 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 622 | $59.61 |
| 87045 | <1% | 45 | $56.46 | |
| 82803 | <1% | 174 | $53.27 | |
| 73620 | <1% | 13 | $50.66 | |
| 86308 | <1% | 68 | $49.53 | |
| 86706 | <1% | 15 | $47.41 | |
| 86708 | <1% | 14 | $47.41 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,929 | $45.61 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 19 | $42.17 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 463 | $36.68 |
| 86702 | <1% | 14 | $35.11 | |
| 87493 | <1% | 30 | $34.91 | |
| 87046 | <1% | 45 | $28.23 | |
| 87899 | <1% | 44 | $28.23 | |
| 87177 | <1% | 29 | $21.57 | |
| 81002 | <1% | 597 | $20.68 | |
| 82270 | <1% | 67 | $15.10 | |
| 82272 | <1% | 61 | $14.23 | |
| 82248 | <1% | 51 | $11.38 | |
| 87015 | <1% | 48 | $8.73 | |
| 36600 | <1% | 14 | $3.71 | |
| 84132 | <1% | 16 | $3.37 | |
| 81015 | <1% | 42 | $2.79 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 1,424 | $2.40 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,718 | $2.31 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,934 | $2.31 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,962 | $1.15 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,701 | $1.02 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,156 | $1.01 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 993 | $0.09 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 931 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 5,235 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 2,088 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 145 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 0% | 15 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 1,443 | $0.00 |
| 94760 | 0% | 1,100 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 2,082 | $0.00 |
| 88304 | 0% | 47 | $0.00 | |
| 96376 | 0% | 1,786 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 802 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 658 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 999 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 0% | 834 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 929 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 1,010 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 480 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 777 | $0.00 |
| 94761 | 0% | 440 | $0.00 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 5,808 | $0.00 |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 0% | 45 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 1,239 | $0.00 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 337 | $0.00 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 0% | 17 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 117 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 32 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 16 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 35 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 1,291 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 1,501 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 706 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 2,859 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 438 | $0.00 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 473 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 1,607 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 239 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 180 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 2,430 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 77 | $0.00 |
| S0164 | Injection, pantoprazole sodium, 40 mg | 0% | 176 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 200 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 5,516 | $0.00 |
| 82009 | 0% | 96 | $0.00 | |
| 82948 | 0% | 48 | $0.00 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 244 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 160 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 51 | $0.00 |
| 51702 | 0% | 12 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMATHIESEN, MATHEW (CFO)
| Provider | Location | Paid |
|---|---|---|
| Sunnyside Community Hospital Association | Sunnyside, WA | $55.09M |
| SHC Medical Center Toppenish | Toppenish, WA | $15.10M |
| SHC Medical Center Toppenish | Union Gap, WA | $4.99M |
| Sunnyside Community Hospital Association | Prosser, WA | $2.35M |
| SHC Medical Center Toppenish | Zillah, WA | $663K |
| SHC Medical Center Toppenish | Toppenish, WA | $381K |
| Sunnyside Community Hospital Association | Union Gap, WA | $316K |
| Sunnyside Community Hospital | Yakima, WA | $51K |
| SHC Medical Center - Yakima | Yakima, WA | $11K |
| Sunnyside Community Hospital | Sunnyside, WA | $4K |
| Sunnyside Community Hospital | Sunnyside, WA | $860.66 |
| Sunnyside Community Hospital Association | Yakima, WA | $839.86 |
| Sunnyside Community Hospital Association | Union Gap, WA | $696.97 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.